375 related articles for article (PubMed ID: 20954275)
1. Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.
Navaneethan U; Venkatesh PG; Shen B
World J Gastroenterol; 2010 Oct; 16(39):4892-904. PubMed ID: 20954275
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment.
Nitzan O; Elias M; Chazan B; Raz R; Saliba W
World J Gastroenterol; 2013 Nov; 19(43):7577-85. PubMed ID: 24282348
[TBL] [Abstract][Full Text] [Related]
3. Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection.
Solanky D; Pardi DS; Loftus EV; Khanna S
Inflamm Bowel Dis; 2019 Feb; 25(3):610-619. PubMed ID: 30260451
[TBL] [Abstract][Full Text] [Related]
4. Clostridium Difficile Infection from a Surgical Perspective.
Kaiser AM; Hogen R; Bordeianou L; Alavi K; Wise PE; Sudan R;
J Gastrointest Surg; 2015 Jul; 19(7):1363-77. PubMed ID: 25917533
[TBL] [Abstract][Full Text] [Related]
5. Managing Clostridium difficile in inflammatory bowel disease (IBD).
Hashash JG; Binion DG
Curr Gastroenterol Rep; 2014; 16(7):393. PubMed ID: 24838421
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile infection and treatment in the pediatric inflammatory bowel disease population.
Mezoff E; Mann EA; Hart KW; Lindsell CJ; Cohen MB
J Pediatr Gastroenterol Nutr; 2011 Apr; 52(4):437-41. PubMed ID: 21407116
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Balram B; Battat R; Al-Khoury A; D'Aoust J; Afif W; Bitton A; Lakatos PL; Bessissow T
J Crohns Colitis; 2019 Jan; 13(1):27-38. PubMed ID: 30247650
[TBL] [Abstract][Full Text] [Related]
8. Management of inflammatory bowel disease with
D'Aoust J; Battat R; Bessissow T
World J Gastroenterol; 2017 Jul; 23(27):4986-5003. PubMed ID: 28785153
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Rao K; Higgins PD
Inflamm Bowel Dis; 2016 Jul; 22(7):1744-54. PubMed ID: 27120571
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease.
Tariq R; Disbrow MB; Dibaise JK; Orenstein R; Saha S; Solanky D; Loftus EV; Pardi DS; Khanna S
Inflamm Bowel Dis; 2020 Aug; 26(9):1415-1420. PubMed ID: 31821444
[TBL] [Abstract][Full Text] [Related]
11. Impact of Clostridium difficile infection on inflammatory bowel disease outcome: a review.
Trifan A; Stanciu C; Stoica O; Girleanu I; Cojocariu C
World J Gastroenterol; 2014 Sep; 20(33):11736-42. PubMed ID: 25206277
[TBL] [Abstract][Full Text] [Related]
12. Clostridioides difficile Infection in Children With Inflammatory Bowel Disease.
Chandrakumar A; Zohni H; El-Matary W
Inflamm Bowel Dis; 2020 Oct; 26(11):1700-1706. PubMed ID: 31765471
[TBL] [Abstract][Full Text] [Related]
13. Recurrent Clostridium difficile infections: the importance of the intestinal microbiota.
Zanella Terrier MC; Simonet ML; Bichard P; Frossard JL
World J Gastroenterol; 2014 Jun; 20(23):7416-23. PubMed ID: 24966611
[TBL] [Abstract][Full Text] [Related]
14. Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.
Singh H; Nugent Z; Yu BN; Lix LM; Targownik LE; Bernstein CN
Gastroenterology; 2017 Aug; 153(2):430-438.e2. PubMed ID: 28479377
[TBL] [Abstract][Full Text] [Related]
15. Anti-TNF containing regimens may be associated with increased risk of Clostridioides difficile infection in patients with underlying inflammatory bowel disease.
Gholam-Mostafaei FS; Yadegar A; Aghdaei HA; Azimirad M; Daryani NE; Zali MR
Curr Res Transl Med; 2020 Aug; 68(3):125-130. PubMed ID: 32414632
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
17. Detecting and treating Clostridium difficile infections in patients with inflammatory bowel disease.
Ananthakrishnan AN
Gastroenterol Clin North Am; 2012 Jun; 41(2):339-53. PubMed ID: 22500522
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and management of Clostridioides difficile infection in patients with inflammatory bowel disease.
Dalal RS; Allegretti JR
Curr Opin Gastroenterol; 2021 Jul; 37(4):336-343. PubMed ID: 33654015
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Meighani A; Hart BR; Bourgi K; Miller N; John A; Ramesh M
Dig Dis Sci; 2017 Oct; 62(10):2870-2875. PubMed ID: 28451916
[TBL] [Abstract][Full Text] [Related]
20. Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.
Wultańska D; Banaszkiewicz A; Radzikowski A; Obuch-Woszczatyński P; Młynarczyk G; Brazier JS; Pituch H; van Belkum A
Eur J Clin Microbiol Infect Dis; 2010 Oct; 29(10):1265-70. PubMed ID: 20577773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
